← Open Payments lookup

SARA HUSSAINI: Open Payments

NPI 1134644057 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$570 in 25 payments from 11 companies in 2025. Trend: 2023 $159 · 2024 $454 · 2025 $570

Food & beverage: $570
CompanyPaymentsAmount
GENZYME CORPORATION3$166
ABBVIE INC.9$141
Takeda Pharmaceuticals U.S.A., Inc.3$65
Celltrion USA Inc.2$45
Janssen Biotech, Inc.2$39
Intercept Pharmaceuticals, Inc.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Braintree Laboratories, Inc.1$20
VIVUS LLC1$20
Ardelyx, Inc.1$17

Products named: DUPIXENT, ENTYVIO, VEGZELMA, RINVOQ, TREMFYA, CREON, LINZESS, SKYRIZI.

Industry payments across FL — which companies pay providers there.